[Analysis of Related Factors for Graft Failure in Umbilical Cord Blood Transplantation for Hematological Diseases].

Authors

Xin-Chen Fang, Chao-Jie Hu, Zhi-Wei Wu, Xiao Xiao, Xiu-Cai Xu, Pan-Pan Huang, Xiang Wan

Published in

Zhongguo shi yan xue ye xue za zhi. Volume 34. Issue 4. Pages 1189-1195.

Abstract

To investigate the early influencing factors of primary graft failure (PGF) following umbilical cord blood transplantation (UCBT).
A retrospective analysis was conducted on the clinical data of 40 patients who underwent UCBT and developed PGF at the First Affiliated Hospital of the University of Science and Technology of China from June 1, 2017 to July 30, 2024. Additionally, 139 patients with successful transplantation during the same period were selected as a control group. Donor chimerism was assessed on day 7, 14, 21, and 30 post-transplantation, and lymphocyte subsets were examined on day 30 post-transplantation.
There were no significant differences between the two groups in baseline characteristics such as disease types, sex, age, and HLA matching status (all P>0.05). The number of infused CD34⁺ cells in the graft failure group was lower than that in the graft success group (P<0.05), and the donor chimerism at each detection time point was significantly lower than that in the graft success group (P<0.001). When the chimerism was lower than 32.6% on day 7 post-transplantation, the sensitivity and specificity for predicting graft failure were 0.825 and 0.884, respectively. The median proportion of CD3⁺CD4⁺CD8^- T cells in lymphocytes in the graft failure group was 12.4% (3.3%-29.8%), which was significantly lower than that in the graft success group ［19.9% (4.4%-56.8%)］ (P=0.001).
The chimerism on day 7 post-UCBT is a potential indicator for predicting graft failure. A lower number of CD34⁺ cells in the umbilical cord blood stem cells used for transplantation and a lower level of CD3⁺CD4⁺CD8^- T cells in the early stage after transplantation may be related to graft failure.

PMID:
42802463
Bibliographic data and abstract were imported from PubMed on 28 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.